Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Calcium Oxalate
2. Calcium Oxalate (1:1)
3. Calcium Oxalate Dihydrate
4. Calcium Oxalate Dihydrate (1:1)
5. Calcium Oxalate Monohydrate (1:1)
6. Calcium Oxalate Trihydrate
7. Dihydrate, Calcium Oxalate
8. Monohydrate, Calcium Oxalate
9. Oxalate, Calcium
10. Trihydrate, Calcium Oxalate
1. 5794-28-5
2. 24804-31-7
3. Calcium;oxalate;hydrate
4. Calcium Oxalate Xhydrate
5. 4pp86kk527
6. Mfcd00150039
7. Unii-4pp86kk527
8. N-undecylether
9. Calcarea Oxalica
10. Calciumoxalatehydrate
11. Ethanedioic Acid, Calcium Salt (1:1), Monohydrate
12. Schembl597632
13. Calcarea Oxalica [hpus]
14. Dtxsid50973513
15. Akos015916111
16. Calcium Ethanedioate--water (1/1/1)
17. Calcium Oxalate Monohydrate, Puratronic(r)
18. Ethanedioic Acid, Calcium Salt, Hydrate (1:1:1)
19. Q27260343
Molecular Weight | 146.11 g/mol |
---|---|
Molecular Formula | C2H2CaO5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 0 |
Exact Mass | 145.9528140 g/mol |
Monoisotopic Mass | 145.9528140 g/mol |
Topological Polar Surface Area | 81.3 Ų |
Heavy Atom Count | 8 |
Formal Charge | 0 |
Complexity | 60.5 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Related Excipient Companies
Excipients by Applications
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Calcium Oxalate Monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calcium Oxalate Monohydrate, including repackagers and relabelers. The FDA regulates Calcium Oxalate Monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calcium Oxalate Monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Calcium Oxalate Monohydrate supplier is an individual or a company that provides Calcium Oxalate Monohydrate active pharmaceutical ingredient (API) or Calcium Oxalate Monohydrate finished formulations upon request. The Calcium Oxalate Monohydrate suppliers may include Calcium Oxalate Monohydrate API manufacturers, exporters, distributors and traders.
Calcium Oxalate Monohydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calcium Oxalate Monohydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Calcium Oxalate Monohydrate GMP manufacturer or Calcium Oxalate Monohydrate GMP API supplier for your needs.
A Calcium Oxalate Monohydrate CoA (Certificate of Analysis) is a formal document that attests to Calcium Oxalate Monohydrate's compliance with Calcium Oxalate Monohydrate specifications and serves as a tool for batch-level quality control.
Calcium Oxalate Monohydrate CoA mostly includes findings from lab analyses of a specific batch. For each Calcium Oxalate Monohydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calcium Oxalate Monohydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Calcium Oxalate Monohydrate EP), Calcium Oxalate Monohydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calcium Oxalate Monohydrate USP).
LOOKING FOR A SUPPLIER?